ARCHIVES

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

This article is from The Cancer Letter archive.

Vol. 34 No. 36 | October 3, 2008

Download PDF Visit The Full Archive

Related Articles

Chabner : Opportunity To Set Own Agenda Reason For Leaving

October 28, 1994

Paraplatin Lengthened TTP In HER2+ Advanced Breast Ca

January 31, 2003

Screening Frequency for Cervical Cancer May Be Reduced, ACS Says

November 22, 2002

Prostate Cancer Patient Groups Consider formation Of Coalition Using the “NBCC Model”

August 16, 1996

New: Special Reports on the Dialogue and NCI’s 2015 goal posted at cancerletter.com.

August 8, 2003

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014